About The Study: Red blood cell (RBC) transfusion was common in patients admitted to 233 intensive care units in 30 countries between 2019 and 2022, with high variability across centers in transfusion ...
Blood transfusion therapy remains an indispensable intervention in the management of sickle cell disease (SCD), mitigating life‐threatening complications such as vaso‐occlusive crises and stroke. The ...
THE DISEASE. THERE IS A CRITICAL NEED FOR BLOOD DONATIONS FOR SICKLE CELL ANEMIA PATIENTS, ESPECIALLY FROM AFRICAN AMERICANS. IT’S REALLY HARD TO DEAL WITH THE SICKNESS. 34 YEAR OLD CORNELIA JONES WAS ...
A woman who has received a breakthrough gene-editing treatment on the NHS is hoping 2026 is the year she will be cured of a ...
Background Up to half of patients with infective endocarditis (IE) require cardiac surgery. Although anaemia is common, its precise prevalence, transfusion practices and impact on outcomes in ...
The past year has offered new hope for patients with lower-risk myelodysplastic syndromes. Besides imetelstat, which has an FDA deadline for action of June 2024, the agency approved luspatercept, ...
An expert explained the burden that red blood cell transfusions can place on patients with MDS. Among patients with myelodysplastic syndromes (MDS), treatment with Reblozyl (luspatercept) resulted in ...
18hon MSN
FDA approves first oral drug for thalassemia anemia, offering new hope beyond blood transfusions
The US FDA has approved the drug Mitapivat, marketed as Aqvesme, as the very first oral therapy for anemia in adults with ...
2don MSN
First Oral Pill For Adults With Thalassemia Anaemia Gets Approval, Experts Hail It As Game Changer
The US Food and Drug Administrations (FDA) approval of the first-ever oral pill for anaemia in adults with thalassemia marks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback